Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Vincent A Deramo, M.D
Long Island Vitreoretinal Consultants
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Retina Vitreous Center
Toms River, New Jersey, United States
- Long Island Vitreoretinal Consultants
Great Neck, New York, United States
- Long Island Vitreoretinal Consultants
Hauppauge, New York, United States
- Long Island Vitreoretinal Consultants
Riverhead, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2010
- Primary completion
- 30 Sept 2014
- Completion
- 30 Sept 2014
- Last update posted
- 3 Apr 2018
- Registered enrollment
- 27
- Registry id
- NCT01231633
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.